Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction.

Source:http://linkedlifedata.com/resource/pubmed/id/11530146

Lancet 2001 Aug 25 358 9282 605-13

Download in:

View as

General Info

PMID
11530146